RARE-21. A DESCRIPTIVE REPORT OF PATIENTS WITH RARE CENTRAL NERVOUS SYSTEM (CNS) CANCERS ON AN NCI-CONNECT CANCER MOONSHOT IMMUNE CHECKPOINT INHIBITOR TRIAL

BACKGROUND: There is increasing interest in the use of immunotherapy in rare CNS tumors, but limited experiences in the clinical evaluation of imaging findings and treatment toxicity in these patients. A phase II clinical trial of Nivolumab, a PD-1 inhibitor, in eleven rare CNS tumors was developed...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Boris, Lisa, Bryla, Christine, Vera, Elizabeth, Aboud, Orwa, Garren, Nancy, Park, Deric, Siegel, Christine, Theeler, Brett, Wu, Jing, Armstrong, Terri, Gilbert, Mark
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Abstracts
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217685/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.995
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items